Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$189,027,789
+$19,676,559 QoQ
Shares Held
2,545,486
+15.0% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. BBIO ranks #3 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in BBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $189,027,789 | 2,545,486 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $169,351,230 | 2,214,031 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $117,008,458 | 2,252,762 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $89,868,504 | 2,081,253 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,874,460 | 83,149 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,055,792 | 80,746 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,677,161 | 224,128 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,921,096 | 417,888 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,336,800 | 924,865 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $35,368,577 | 1,341,243 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,087,359 | 1,632,986 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,006,908 | 2,232,021 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,580,278 | 2,700,824 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $23,439,205 | 2,358,069 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,232,007 | 2,448,459 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $25,334,684 | 2,496,028 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,451,964 | 1,286,089 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,808,167 | 166,592 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,286,024 | 168,734 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,586,754 | 25,759 | Shares | Defined | 2021-05-17 | |
| 2020-03-31 | $3,265,081 | 112,589 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||